These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
164 related articles for article (PubMed ID: 11021735)
41. A correlation between cytotoxicity and reductase-mediated metabolism in cell lines treated with doxorubicin and daunorubicin. Bains OS; Szeitz A; Lubieniecka JM; Cragg GE; Grigliatti TA; Riggs KW; Reid RE J Pharmacol Exp Ther; 2013 Nov; 347(2):375-87. PubMed ID: 23995598 [TBL] [Abstract][Full Text] [Related]
42. NTP Toxicology and Carcinogenesis Studies of Pentachloroanisole (CAS No. 1825-21-4) in F344 Rats and B6C3F1 Mice (Feed Studies). National Toxicology Program Natl Toxicol Program Tech Rep Ser; 1993 Apr; 414():1-284. PubMed ID: 12616284 [TBL] [Abstract][Full Text] [Related]
43. Angelica sinensis: a novel adjunct to prevent doxorubicin-induced chronic cardiotoxicity. Xin YF; Zhou GL; Shen M; Chen YX; Liu SP; Chen GC; Chen H; You ZQ; Xuan YX Basic Clin Pharmacol Toxicol; 2007 Dec; 101(6):421-6. PubMed ID: 17971065 [TBL] [Abstract][Full Text] [Related]
44. Effects of curcumin on the pharmacokinetics of tamoxifen and its active metabolite, 4-hydroxytamoxifen, in rats: possible role of CYP3A4 and P-glycoprotein inhibition by curcumin. Cho YA; Lee W; Choi JS Pharmazie; 2012 Feb; 67(2):124-30. PubMed ID: 22512082 [TBL] [Abstract][Full Text] [Related]
45. Effect of methimazole treatment on doxorubicin-induced cardiotoxicity in mice. Osman AM; Nemnem MM; Abou-Bakr AA; Nassier OA; Khayyal MT Food Chem Toxicol; 2009 Oct; 47(10):2425-30. PubMed ID: 19577608 [TBL] [Abstract][Full Text] [Related]
46. NTP technical report on the toxicity studies of Dibutyl Phthalate (CAS No. 84-74-2) Administered in Feed to F344/N Rats and B6C3F1 Mice. Marsman D Toxic Rep Ser; 1995 Apr; 30():1-G5. PubMed ID: 12209194 [TBL] [Abstract][Full Text] [Related]
47. Direct comparison of two pegylated liposomal doxorubicin formulations: is AUC predictive for toxicity and efficacy? Cui J; Li C; Guo W; Li Y; Wang C; Zhang L; Zhang L; Hao Y; Wang Y J Control Release; 2007 Apr; 118(2):204-15. PubMed ID: 17239468 [TBL] [Abstract][Full Text] [Related]
48. The novel anthracenedione, pixantrone, lacks redox activity and inhibits doxorubicinol formation in human myocardium: insight to explain the cardiac safety of pixantrone in doxorubicin-treated patients. Salvatorelli E; Menna P; Paz OG; Chello M; Covino E; Singer JW; Minotti G J Pharmacol Exp Ther; 2013 Feb; 344(2):467-78. PubMed ID: 23192654 [TBL] [Abstract][Full Text] [Related]
49. Toxicology and carcinogenesis studies of 2,3,4,7,8-pentachlorodibenzofuran (PeCDF) (Cas No. 57117-31-4) in female Harlan Sprague-Dawley rats (gavage studies). National Toxicology Program Natl Toxicol Program Tech Rep Ser; 2006 Sep; (525):1-198. PubMed ID: 17160103 [TBL] [Abstract][Full Text] [Related]
50. Pharmacology of N,N-di(n-butyl)adriamycin-14-valerate in the rat. Han G; Israel M; Seshadri R; Dalton JT; Sweatman TW Cancer Chemother Pharmacol; 1996; 37(5):472-8. PubMed ID: 8599871 [TBL] [Abstract][Full Text] [Related]
51. The efficacy of selenium, WR-2721, and their combination in the prevention of adriamycin-induced cardiotoxicity in rats. Dobrić S; Dragojević-Simić V; Bokonjić D; Milovanović S; Marincić D; Jović P J Environ Pathol Toxicol Oncol; 1998; 17(3-4):291-9. PubMed ID: 9726805 [TBL] [Abstract][Full Text] [Related]
52. NTP Toxicology and Carcinogenesis Studies of 3,4-Dihydrocoumarin (CAS No. 119-84-6) in F344/N Rats and B6C3F1 Mice (Gavage Studies). National Toxicology Program Natl Toxicol Program Tech Rep Ser; 1993 Sep; 423():1-336. PubMed ID: 12616288 [TBL] [Abstract][Full Text] [Related]
53. General oxidative stress during doxorubicin-induced cardiotoxicity in rats: absence of cardioprotection and low antioxidant efficiency of alpha-lipoic acid. Ghibu S; Delemasure S; Richard C; Guilland JC; Martin L; Gambert S; Rochette L; Vergely C Biochimie; 2012 Apr; 94(4):932-9. PubMed ID: 21396425 [TBL] [Abstract][Full Text] [Related]
54. Effect of sublethal liver injury on doxorubicin metabolism. August DA; Halter S; Brenner DE Clin Cancer Res; 1995 Mar; 1(3):351-8. PubMed ID: 9815991 [TBL] [Abstract][Full Text] [Related]
55. Pharmacokinetic-toxicodynamic relationships of adriamycin in rat: prediction of butylated hydroxyanisole-mediated reduction in anthracycline cardiotoxicity. Vora J; Boroujerdi M J Pharm Pharmacol; 1996 Dec; 48(12):1264-9. PubMed ID: 9004189 [TBL] [Abstract][Full Text] [Related]
56. Impact of endotoxin-induced changes in P-glycoprotein expression on disposition of doxorubicin in mice. Hartmann G; Vassileva V; Piquette-Miller M Drug Metab Dispos; 2005 Jun; 33(6):820-8. PubMed ID: 15778272 [TBL] [Abstract][Full Text] [Related]
57. Use of cardiac troponin T levels as an indicator of doxorubicin-induced cardiotoxicity. Herman EH; Lipshultz SE; Rifai N; Zhang J; Papoian T; Yu ZX; Takeda K; Ferrans VJ Cancer Res; 1998 Jan; 58(2):195-7. PubMed ID: 9443390 [TBL] [Abstract][Full Text] [Related]
58. Effect of allyl alcohol-induced sublethal hepatic damage upon doxorubicin metabolism and toxicity in the rabbit. Brenner DE; Anthony LB; Halter S; Harris NL; Collins JC; Hande KR Cancer Res; 1987 Jun; 47(12):3259-65. PubMed ID: 3581067 [TBL] [Abstract][Full Text] [Related]
59. Doxorubicin irreversibly inactivates iron regulatory proteins 1 and 2 in cardiomyocytes: evidence for distinct metabolic pathways and implications for iron-mediated cardiotoxicity of antitumor therapy. Minotti G; Ronchi R; Salvatorelli E; Menna P; Cairo G Cancer Res; 2001 Dec; 61(23):8422-8. PubMed ID: 11731422 [TBL] [Abstract][Full Text] [Related]
60. Electrocardiographic and biochemical evidence for the cardioprotective effect of vitamin E in doxorubicin-induced acute cardiotoxicity in rats. Puri A; Maulik SK; Ray R; Bhatnagar V Eur J Pediatr Surg; 2005 Dec; 15(6):387-91. PubMed ID: 16418954 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]